Facility #1

Nashville, Tennessee 37212

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Breast Neoplasm

Studies at this site

• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) — Completed
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early